Double Down on Single-Tablet Combination Therapy in Pulmonary Arterial Hypertension: Possible Benefits for Selected Patients

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)485-487
Number of pages3
JournalJournal of the American College of Cardiology
Volume83
Issue number4
DOIs
Publication statusPublished - 30 Jan 2024

Keywords

  • macitentan
  • pulmonary arterial hypertension
  • randomized controlled trial
  • single-tablet (fixed-dose) combination therapy
  • tadalafil

Cite this